Loading

Seroprevalence of Toxoplasma gondii Infection among HIVInfected Patients in Tokyo, Japan

Research Article | Open Access

  • 1. Departmentof General Medicine, Juntendo University School of Medicine, Japan
  • 2. Research Support Center, Juntendo University Graduate School of Medicine, Japan
  • 3. Department of Infection Control Science, Juntendo University School of Medicine, Japan
  • 4. Department of Parasitology, Taipei Medical University College of Medicine, Taiwan
  • 5. Center for International Tropical Medicine, Taipei Medical University College of Medicine, Taipei, Taiwan
+ Show More - Show Less
Corresponding Authors
Toshio Naito, Department of General Medicine, Juntendo University School of Medicine Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan, Tel: +81-3-3813-3111; Fax: +81-3-5802-1190
Abstract

The seroprevalence of IgG antibodies against Toxoplasma gondii was assessed in 169 adult non-hemophiliac Japanese patients infected with human immunodeficiency virus. The seroprevalence of T. gondii infection was only 14.2%, which was similar to findings from the USA and lower than that reported for most other countries. The positive ratio of T. gondii IgG antibodies was significantly higher in patients aged ≥ 40 years (21.0% vs. 7.9%, p=0.01) with < 200 CD4+ cells /µL (20.5% vs. 9.4%, p=0.04). Group analysis showed that seropositivity did not differ according to sexuality. The ratios of positivity for hepatitis B surface antigen, hepatitis B surface antibody, hepatitis C antibody, serological findings for syphilis and the findings of the Treponema pallidum hemaggulation test were not associated the seroprevalence of IgG antibodies against T. gondii.

These results indicate that patients in Japan with lesions of the central nervous system and antibodies against T. gondii are highly likely to have toxoplasmosis. Infection with T. gondii should be carefully assessed in elderly Japanese patients who are infected with human immunodeficiency virus.

Citation

Takahashi H, Tsubouchi A, Murai K, Yamanouchi M, Tanei M, et al. (2014) Seroprevalence of Toxoplasma gondii Infection among HIV- Infected Patients in Tokyo, Japan. Clin Res HIV/AIDS 1(2): 1007.

Keywords

•    Acquired immune deficiency syndrome
•    Toxoplasmosis
•    Hepatitis B virus
•    Hepatitis C virus
•    Syphilis
•    Opportunistic infection

INTRODUCTION

Toxoplasma encephalitis (TE) represents an important opportunistic infection in patients infected with human immunodeficiency virus (HIV). Measuring IgG antibodies to T. gondii is crucial, because the risk of developing cerebral toxoplasmosis is high among HIV-seropositve individuals. Therefore, HIV-infected patients with Toxoplasma antibodies must start oral pharmacotherapy as toxoplasmosis prophylaxis. Nissapatorn et al. reported that almost half (44.4%) of patients who are infected with HIV or have acquired immunodeficiency syndrome (AIDS) in Malaysia are seropositive for Toxoplasma [1], and seropositive ratios are also high in other countries except the USA [2-6]. We previously reported a very low seroprevalence (5.4%) in non-symptomatic Japanese patients [7].

However, differences such as age, sexuality or number of CD4 positive cells among subgroups of patients have not been discussed. Also, relationships between these seroprevalence of Toxoplasma antibodies and seropositivity to HBV, HCV and syphilis remains unclear. Seroprevalence might differ with race, region and era and thus, these issues should also be investigated in Japan. The results of such an investigation would help to determine clinical diagnoses. In present study, we investigated the prevalence of antibodies against Toxoplasma among Japanese patients infected with HIV.

PATIENTS AND METHODS

The Department of General Medicine at Juntendo University provided care to 257 patients with documented HIV infection from 1990 to 2012 in central Tokyo. Test for IgG antibodies to T. gondii has been a routine part of the initial assessment of all HIVinfected patients since 1990. Patients who missed the test were excluded from the statistical analysis. The study group comprised only Japanese patients living in Japan who were infected with non-hemophiliac HIV.

Serological test for IgG anti-Toxoplasma antibodies was employed by using enzyme-linked immunosorbent assays (ELISA) at a commercial testing laboratory (SRL, Tokyo, Japan). Chemiluminescence enzyme immunoassays (CLEIA) were used to test for HIV antibody, hepatitis B surface antigen (HBs Ag), hepatitis B surface antibody (HBs Ab) and hepatitis C virus antibody (HCV Ab), and Treponema pallidum was assessed by hemagglutination (TPHA) assays.

Statistical comparisions were done by using the chi-square test. Values of p<0.05 were considered statistically significant.

RESULTS

Toxoplasma IgG antibody results were available from 169 (male, n = 163; female; n = 6; mean age, 33 y; range, 21 - 75 y) of the 257 patients. Table 1 shows details of the patients. Most of them had acquired HIV through a sexual route, 49.7% being men who have sex with men (MSM) and 19.5% being heterosexual. Only one patient had a history of intravenous drug use. Of the 169 patients, 43.2% had a baseline CD4+ lymphocyte count < 200/μL (mean ± SD, 274.9 ± 248/μL).

Twenty four (14.2%) of the 169 patients had serological evidence of T. gondii infection. Figure 1 shows that the prevalence was increased by advancing age, especially in those > 40 y. The probability of being seropositive to T. gondii was significantly higher for patients whose age was greater than 40 years (21.0% vs. 7.9%: p=0.01; Table 2). The numbers of CD4+ cells were statistically significant; 20.5% and 9.4% of patients had < 200 and ≥ 200 CD4+ cells/µL, respectively (p=0.04). Sexuality did not significantly differ among the groups.

Seroprevalence did not significantly differ among positive ratios of HBs Ag, HBs Ab, HCV Ab, serological outcomes of syphilis (STS) and the TPHA test (Table 3). However, the seroprevalence of T. gondii seemed higher in patients with positive STS (p=0.09).

DISCUSSION

With the emergence of individuals infected with HIV in Japan, T. gondii has become an important opportunistic pathogen, especially in the central nervous system.T. gondii can reactivate and cause cerebral toxoplasmosis, usually when the CD4+ lymphocyte count falls less than 100/µL [8-10]. The incidence of TE in patients infected with HIV depends mainly on the existence of latent anti-Toxoplasma antibodies in the population [11,12].

Therefore, to understand the seroprevalence of these antibodies in HIV-infected individuals is very important.

The local prevalence of Toxoplasma antibodies in HIV-infected patients might depend on that in healthy adults. Yamaoka and Konishi showed that the seroprevalence of IgG anti-Toxoplasma antibodies among 2,564 healthy Japanese was 9.3% in 1993 [13]. Our previous study found a similar seroprevalence (7.1%) as compared to that reported [7]. T. gondii typically infects humans who have ingested tissue cysts in undercooked meat from an infected animal, or by ingesting infectious oocysts from the environment, usually from soil contaminated with feline feces [14-16]. Lower prevalence might be related to a lower risk in exposure to T. gondii infection, reflecting the dietary habits and better sanitary conditions in Japan.

These results might also explain the lower incidence of TE in Japan. One study found that only 1.07% of Japanese patients infected with HIV had toxoplasmosis [17]. TE is often difficult to distinguish from malignant lymphoma or progressive multifocal leukoencephalopathy in patients infected with HIV. However, the present results suggest that patients in Japan with lesions of the central nervous system and antibodies to T. gondii have a high probability of having TE.

It has been indicated that up to one third of the global population is infected with T. gondii [18]. As most toxoplasma infections among humans arise due to consuming undercooked or raw meat containing tissue cysts or by exposure to oocysts through ingesting food and water contaminated with cat feces. However, the incidence of toxoplasmosis among patients with AIDS with and without cats does not significantly differ [19]. One study from the USA indicates that persons who have HIV with ages ≥ 50 years were more likely to have antibodies to T. gondii [20]. Our data confirmed a similar tendency in a Japanese population.

Our present study found the seroprevalence of anti-Toxoplasma IgG antibody was higher among patients with low CD4+ cell counts (Table 2). Mice deficient in CD4 have impaired resistance to tachyzoites and HIV infection increases susceptibility to T. gondii infection [21]. The present findings are also compatible with those of a Nigerian study [22].

The relationship between T. gondii infection and sexual contact that can result in HBV, HCV or syphilis is unclear. We did not find a statistical relationship between toxoplasmosis and the seroprevalence of HBV, HCV or syphilis.

This retrospective study did not have information regarding basic risk factors such as cat ownership, dietary habits, soil exposure and other important risk factors for disease acquisition. Moreover, the number of serum samples was insufficient due to limited resources, and thus, the statistical power is lower. The present findings should be interpreted in light of these limitations.\

Table 1: HIV-infected patients who were infected by Toxoplasma gondiiinfection.

Factor n  
Median age (range; y) 169 33 (21 - 75)
Mean CD4
(± SD; cells/µL)
169 274.9 ± 248
Mean HIV RNA
(range; copies/mL)
124 3.4x10^{4} (0 - 3.4x10^{5})

Table 2: Seroprevalence of anti-Toxoplasma gondii antibody according to age, sexuality and CD4+ cells.

Factor n Toxoplasma IgG 
% (n) 
P Odds ratio
Age (y) 169 < 40 
7.9 (7)
≥ 40 
21.0 (17) 
0.01* 3.16
Sexuality 122 MSM 
10.1 (9) 
Hetero 
18.1 (6) 
0.23 0.51
CD4+ cells
(/µL)
169 < 200 
20.5 (15)
≥ 200 
9.4 (9) 
0.04* 0.40

Table 3: Association between Toxoplasma gondii and other infections.

Factor n Toxoplasma IgG 
% (n) 
P Odds ratio
    Positive Negative    
HBs Ag 147 5.3 (1) 7.0 (9) 0.84 0.73
HBs Ab 69 142.9 (3) 48.4 (30) 0.90 0.80
HCV Ab 147 5.3 (1) 3.1(4) 0.84 1.72
STS 142 43.8 (7) 123.8 (30)

0.09

2.49
TPHA 131 50.0 (7) 144.4 (52) 0.69 1.25

HBs Ab, hepatitis B surface antibody; HBs Ag, hepatitis B surface antigen; 
HCV Ab, hepatitis C virus antibody; STS, serological test for syphilis; 
TPHA, Treponema pallidum hemagglutination.

CONCLUSIONS

The seroprevalence of anti-Toxoplasma IgG antibody among Japanese persons infected with HIV was determined. Although the rate was relatively lower that those elsewhere, our findings indicated that 14.2% of HIV positive patients in Japan are at risk of developing life-threatening, secondary reactivation of cerebral toxoplasmosis in association with AIDS. The seroprevalence of T. gondii significantly varies among subpopulations of patients with HIV, especially age groups. Therefore, individual subgroup analyses are required. Youth should also be educated to minimize risk and prevent new Toxoplasma infections arising.

FINANCIAL SUPPORT

This study was supported by a Grant-in-Aid (S1201013) from the MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for Strategic Research Foundations at Private Universities, 2012-2017.

REFERENCES

1. Nissapatorn V, Lee C, Quek KF, Leong CL, Mahmud R, Abdullah KA. Toxoplasmosis in HIV/AIDS patients: a current situation. Jpn J Infect Dis. 2004; 57: 160-165.

2. Meisheri YV, Mehta S, Patel U. A prospective study of seroprevalence of Toxoplasmosis in general population, and in HIV/AIDS patients in Bombay, India. J Postgrad Med. 1997; 43: 93-97.

3. Israelski DM, Chmiel JS, Poggensee L, Phair JP, Remington JS. Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis. J Acquir Immune Defic Syndr. 1993; 6: 414-418.

4. Holliman RE. Serological study of the prevalence of toxoplasmosis in asymptomatic patients infected with human immunodeficiency virus. Epidemiol Infect. 1990; 105: 415-418.

5. Sýkora J, Zást?ra M, Stanková M. Toxoplasmic antibodies in sera of HIV-infected persons. Folia Parasitol (Praha). 1992; 39:177-80

6. Uneke CJ, Duhlinska DD, Njoku MO, Ngwu BA. Seroprevalence of acquired toxoplasmosis in HIV-infected and apparently healthy individuals in Jos, Nigeria. Parassitologia. 2005; 47: 233-236.

7. Naito T, Inui A, Kudo N, Matsumoto N, Fukuda H, Isonuma H, Sekigawa I. Seroprevalence of IgG anti-toxoplasma antibodies in asymptomatic patients infected with human immunodeficiency virus in Japan. Intern Med. 2007; 46: 1149-1150.

8. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992; 15: 211-222.

9. Renold C, Sugar A, Chave JP, Perrin L, Delavelle J, Pizzolato G, Burkhard P. Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine (Baltimore). 1992; 71: 224- 239.

10. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992; 327: 1643-1648.

11. Grant IH, Gold JW, Rosenblum M, Niedzwiecki D, Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS. 1990; 4: 519- 521.

12. Holliman RE. Serological study of the prevalence of toxoplasmosis in asymptomatic patients infected with human immunodeficiency virus. Epidemiol Infect. 1990; 105: 415-418.

13. Yamaoka M, Konishi E. Prevalence of antibody to Toxoplasma gondii among inhabitants under different geographical and climatic conditions in Hyogo Prefecture, Japan. Jpn J Med Sci Biol. 1993; 46: 121-129.

14. Dawson D. Food borne protozoan parasites. Int J Food Microbiol. 2005; 103: 207-227.

15. Weigel RM, Dubey JP, Dyer D, Siegel AM. Risk factors for infection with Toxoplasma gondii for residents and workers on swine farms in Illinois. Am J Trop Med Hyg. 1999; 60: 793-798.

16. Dubey JP. Toxoplasmosis - a waterborne zoonosis. Vet Parasitol. 2004; 126: 57-72.

17. Kano S, Genka I, Yoshida K, et al. Parasitic disease complicated with HIV/AIDS patients in Japan. Clinical Parasitology. 15: 95-98,2004.

18. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004; 363: 1965- 1976.

19. Wallace MR, Rossetti RJ, Olson PE. Cats and toxoplasmosis risk in HIVinfected adults. JAMA. 1993; 269: 76-77.

20. Falusi O, French AL, Seaberg EC, Tien PC, Watts DH, Minkoff H, Piessens E. Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection. Clin Infect Dis. 2002; 35: 1414-1417.

21. Johnson LL, Sayles PC. Deficient humoral responses underlie  susceptibility to Toxoplasma gondii in CD4-deficient mice. Infect Immun. 2002; 70: 185-191.

22. Osunkalu VO, Akanmu SA, Ofomah NJ, Onyiaorah IV, Adediran AA, Akinde RO, Onwuezobe IA. Seroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the Lagos University Teaching Hospital. HIV AIDS (Auckl). 2011; 3: 101-105

Received : 28 Mar 2014
Accepted : 07 Jun 2014
Published : 09 Jun 2014
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X